STELLA PHARMA CORPORATION's total assets for Q4 2024 were ¥5.42B, an increase of 6.70% from the previous quarter. JP:4888 total liabilities were ¥2.21B for the fiscal quarter, a 5.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.